References

Abdel-Kader K, Myaskovsky L, Karpov I Individual quality of life in chronic kidney disease: influence of age and dialysis modality. Clin J Am Soc Nephrol.. 2009; 4:(4)711-718 https://doi.org/10.2215/CJN.05191008

Al Awwa IA, Jallad SG. Prevalence of depression in Jordanian haemodialysis patients. Iranian Journal of Psychiatry and Behavioural Science.. 2018; 12:(2)1-5 https://doi.org/10.5812/ijpbs.11286

Al-Ghabeesh SH, Alshraifeen AA, Saifan AR, Bashayreh IH, Alnuaimi KM, Masalha HA. Spirituality in the lives of patients with end-stage renal disease: a systematic review. J Relig Health.. 2018; 57:(6)2461-2477 https://doi.org/10.1007/s10943-018-0622-2

National registry of end stage renal disease (ESRD). Annual report 2016. 2016. https://tinyurl.com/y3wmmuhq (accessed 11 November 2020)

Alradaydeh MF, Khalil AA. The association of spiritual well-being and depression among patients receiving hemodialysis. Perspect Psychiatr Care.. 2018; 54:(3)341-347 https://doi.org/10.1111/ppc.12249

Al Sayah F, Ishaque S, Lau D, Johnson JA. Health related quality of life measures in Arabic speaking populations: a systematic review on cross-cultural adaptation and measurement properties. Qual Life Res.. 2013; 22:(1)213-229 https://doi.org/10.1007/s11136-012-0129-3

Alshraifeen A, McCreaddie M, Evans JMM. Quality of life and well-being of people receiving haemodialysis treatment in Scotland: A cross-sectional survey. Int J Nurs Pract.. 2014; 20:(5)518-523 https://doi.org/10.1111/ijn.12194

Andreoulakis E, Hyphantis T, Kandylis D, Iacovides A. Depression in diabetes mellitus: a comprehensive review. Hippokratia.. 2012; 16:(3)205-214

Bravin AM, Trettene ADS, Andrade LGM, Popim RC. Benefits of spirituality and/or religiosity in patients with chronic kidney disease: an integrative review. Rev Bras Enferm.. 2019; 72:(2)541-551 https://doi.org/10.1590/0034-7167-2018-0051

Centers for Disease Control and Prevention. CDC in Jordan: Factsheet. 2013. https://www.cdc.gov/globalhealth/countries/jordan/pdf/jordan.pdf (accessed 11 November 2020)

Dąbrowska-Bender M, Dykowska G, Żuk W, Milewska M, Staniszewska A. The impact on quality of life of dialysis patients with renal insufficiency. Patient Prefer Adherence.. 2018; 12:577-583 https://doi.org/10.2147/PPA.S156356

Davison SN, Simpson C. Hope and advance care planning in patients with end stage renal disease: qualitative interview study. BMJ.. 2006; 333:(7574)886-889 https://doi.org/10.1136/bmj.38965.626250.55

Farran CJ, Herth KA, Popovich JM. Hope and hopelessness: Critical clinical constructs.Thousand Oaks (CA): Sage; 1995

Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods.. 2007; 39:(2)175-191 https://doi.org/10.3758/BF03193146

Fradelos E, Tzavella F, Koukia E Integrating chronic kidney disease patient's spirituality in their care: health benefits and research perspectives. Mater Sociomed.. 2015; 27:(5)354-358 https://doi.org/10.5455/msm.2015.27.354-358

Ghazavi Z, KhalediSardashti F, Keshani F, Smaeilzadeh M. Effect of hope therapy on the mood status of patients with diabetes. Iran J Nurs Midwifery Res.. 2018; 23:(4)281-286 https://doi.org/10.4103/ijnmr.IJNMR_36_16

Hallab A, Wish JB. Employment among patients on dialysis. Clin J Am Soc Nephrol.. 2018; 13:(2)203-204 https://doi.org/10.2215/cjn.13491217

Herth K. Relationship of hope, coping styles, concurrent losses, and setting to grief resolution in the elderly widow(er). Res Nurs Health.. 1990; 13:(2)109-117 https://doi.org/10.1002/nur.4770130207

Herth K. Abbreviated instrument to measure hope: development and psychometric evaluation. J Adv Nurs.. 1992; 17:(10)1251-9 https://doi.org/10.1111/j.1365-2648.1992.tb01843.x

Jahromi MK, Poorgholami F, Rahmanian F, Rahmanian E. Effects of self-care education with telephone follow-up on self-efficacy level in hemodialysis patients. Biosciences Biotechnology Research Asia.. 2016; 13:(1)375-381 https://doi.org/10.13005/bbra/2043

Khalil AA, Abed MA, Ahmad M, Mansour AH. Under-diagnosed chronic kidney disease in Jordanian adults: prevalence and correlates. J Ren Care.. 2018; 44:(1)12-18 https://doi.org/10.1111/jorc.12214

Kara B. Treatment-related stress and coping: an important consideration in patients on hemodialysis. Nursing and Palliative Care. 2018; 3:(2) https://doi.org/10.15761/NPC.1000179

Khodabakhshi-Koolaee A, Mosalanejad L, Gholami M, Massah O. Effectiveness of group hope therapy on the psychological indicators in women with addicted husbands. Iranian Rehabilitation Journal.. 2017; 15:(1)15-22 https://doi.org/10.18869/nrip.irj.15.1.15

Ma TK-W, Li PK-T. Depression in dialysis patients. Nephrology (Carlton).. 2016; 21:(8)639-46 https://doi.org/10.1111/nep.12742

Melo GAA, Silva RA, Silva MFC, Galvão MTG, Silva VM, Caetano JÁ. Religiosity and hope in patients with chronic renal failure: coping strategies. Int Arch Med.. 2016; 9:(133)1-9 https://doi.org/10.3823/2004

National Kidney Foundation. What is kidney failure?. 2020. https://www.kidney.org/atoz/content/KidneyFailure (accessed 11 November 2020)

Muscat DM, Kanagaratnam R, Shepherd HL, Sud K, McCaffery K, Webster A. Beyond dialysis decisions: a qualitative exploration of decision-making among culturally and linguistically diverse adults with chronic kidney disease on haemodialysis. BMC Nephrol.. 2018; 19:(1) https://doi.org/10.1186/s12882-018-1131-y

Orlandi F, de S, Pepino BG, Pavarini SC, Dos Santos DA, de Mendiondo MS. Avaliação do nível de esperança de vida de idosos renais crônicos em hemodiálise [The evaluation of the level of hope of elderly chronic kidney disease patients undergoing hemodialysis]. Article in Portuguese. Rev Esc Enferm USP.. 2012; 46:(4)900-905 https://doi.org/10.1590/s0080-62342012000400017

Ottaviani AC, Souza ÉN, Drago N, De Mendiondo MSZ, Pavarini SCI, Orlandi F. Esperança e espiritualidade de pacientes renais crônicos em hemodiálise: estudo correlacional. [Hope and spirituality of chronic kidney patients on hemodialysis: correlational study]. Article in Portuguese. Rev Lat Am Enfermagem.. 2014; 22:(2)248-254 https://doi.org/10.1590/0104-1169.3323.2409

Rahimipour M, Shahgholian N, Yazdani M. Effect of hope therapy on depression, anxiety, and stress among the patients undergoing hemodialysis. Iran J Nurs Midwifery Res.. 2015; 20:(6)694-699 https://doi.org/10.4103/1735-9066.170007

Saffari M, Pakpour AH, Naderi MK, Koenig HG, Baldacchino DR, Piper CN. Spiritual coping, religiosity and quality of life: a study on Muslim patients undergoing haemodialysis. Nephrology (Carlton).. 2013; 18:(4)269-275 https://doi.org/10.1111/nep.12041

Sahaf R, Sadat Ilali E, Peyrovi H, Akbari Kamrani AA, Spahbodi F. Uncertainty, the overbearing lived experience of the elderly people undergoing haemodialysis: a qualitative study. Int J Community Based Nurs Midwifery.. 2017; 5:(1)13-21

Santos PR, Capote Júnior JRFG, Cavalcante Filho JRM, Ferreira TP, dos Santos Filho JNG, da Silva Oliveira S. Religious coping methods predict depression and quality of life among end-stage renal disease patients undergoing hemodialysis: a cross-sectional study. BMC Nephrol.. 2017; 18:(1) https://doi.org/10.1186/s12882-017-0619-1

Scanlon C. Creating a vision of hope: the challenge of palliative care. Oncol Nurs Forum.. 1989; 16:(4)491-496

Silva SM, Braido NF, Ottaviani AC, Gesualdo GD, Zazzetta MS, Orlandi FS. Social support of adults and elderly with chronic kidney disease on dialysis. Rev Lat Am Enfermagem.. 2016; 24:(0) https://doi.org/10.1590/1518-8345.0411.2752

Snyder CR. Hope theory: rainbows in the mind. Psychological Inquiry.. 2002; 13:(4)249-275 https://doi.org/10.1207/S15327965PLI1304_01

Taheri-Kharameh Z. The relationship between spiritual well-being and stress coping strategies in haemodialysis patients. Health. Spirituality and Medical Ethics.. 2016; 3:(4)24-28

Tamadon A, Askari M. Evaluate the effectiveness of hope therapy on improving resilience of patients with blood cancer. Journal of UMP Social Science and Technology Management.. 2015; 3:(3)358-362

World Health Organization. WHOQOL-BREF: introduction, administration, scoring and generic version of the assessment. Field trial version. 1996. https://www.who.int/mental_health/media/en/76.pdf (accessed 11 November 2020)

Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine.. 1998; 28:(3)551-558 https://doi.org/10.1017/s0033291798006667

Yucens B, Ozan Kotan V, Ozkayar N The association between hope, anxiety, depression, coping strategies and perceived social support in patients with chronic kidney disease. Dusunen Adam: The Journal of Psychiatry and Neurological Sciences.. 2019; 32:(1)43-51 https://doi.org/10.14744/DAJPNS.2019.00006

Zhou X, Xue F, Wang H The quality of life and associated factors in patients on maintenance hemodialysis – a multicenter study in Shanxi province. Ren Fail.. 2017; 39:(1)707-711 https://doi.org/10.1080/0886022X.2017.1398095

The association between hope and quality of life in haemodialysis patients

26 November 2020
Volume 29 · Issue 21

Abstract

Background:

Hope is important for patients with end-stage renal disease receiving haemodialysis (HD) and hope is associated with quality of life (QoL). Studies examining hope among the HD population are limited and, as far as the authors know, have not been undertaken in Jordan.

Aims:

To examine levels of hope and QoL and to examine the association between hope and QoL in HD patients in Jordan.

Methods:

A cross-sectional design was used. A convenience sample of 202 patients from six different dialysis centres was recruited. The World Health Organization QOL-BREF and the Herth Hope Index were used.

Findings:

Moderate levels of hope (M=32.3±4.1) were reported. Respondents reported low mean scores for the physical domain of QoL (M=48.3±21.1) but not for the psychological and social relationship domains. Higher hope scores were associated with better QoL.

Conclusion:

The findings suggest a positive relationship between the level of hope and QoL in people receiving HD. Encouraging hope while caring for HD patients in clinical settings may improve their QoL. Understanding the relationship between hope and QoL may help healthcare providers to improve the quality of care for patients and their families.

End-stage renal disease (ESRD) is characterised by losing 85% or more of the kidneys' functioning (National Kidney Foundation, 2020). It is considered one of the major diseases that affect the quality of life (QoL) of patients (Rahimipour et al, 2015). In Jordan, the total number of patients with ESRD by the end of 2016 was 5352; of them, 5130 patients were receiving haemodialysis (HD) treatment and 380 patients out of the 5130 HD patients died during that same year. In the latest report from Jordan, the number of new cases of ESRD for the year 2016 was 829 patients, which is considered a significant rise when compared with previous years (Al-Quaisi and Assad, 2016). In addition, there is a high rate of under-diagnosed renal disease among Jordanians (Khalil et al, 2018). According to the Centers for Disease Control and Prevention (CDC) (2013), renal disease is among the top 10 causes of death in Jordan (4%), which also include ischaemic heart disease at 18% and diabetes at 7%.

Patients with ESRD receiving HD treatment may have many physical problems that affect their QoL, such as increased urea, joint pain, electrolyte imbalance, hypertension and heart problems (Orlandi et al, 2012; Saffari et al, 2013; Khalil et al, 2018), fatigue, sleep disturbances, nutritional constraints, pain and limited physical activities (Alshraifeen et al, 2014; Santos et al, 2017; Al Awwa and Jallad, 2018). These patients also face psychological challenges, including disturbances in body image, feelings of hopelessness, low self-esteem and helplessness, and dependency on family members, healthcare providers and the use of technology (Rahimipour et al, 2015; Daąbrowska-Bender et al, 2018). Stress, anxiety, uncertainty, and depression are also common (Sahaf and Ilali, 2017; Alradaydeh and Khalil, 2018; Al Awwa and Jallad, 2018). The number of patients diagnosed with psychiatric problems such as depression, schizophrenia and dementia in the ESRD population is substantially higher than that observed in patients with other chronic illnesses (Saffari et al, 2013; Kara, 2018). For example, the prevalence of depression among patients with ESRD is 22.8% to 39.3% (Ma and Li, 2016), while in diabetes it is 12% (Andreoulakis et al, 2012). Thus, patients struggling with chronic diseases such as ESRD may often engage in a process of thinking and rethinking about the meaning of life and death (Ottaviani et al, 2014; Fradelos et al, 2015)

Hope is a valuable human response that has received increasing attention in recent years (Fradelos et al, 2015; Melo et al, 2016). Taheri-Kharameh (2016) perceived hope as important to human life as it provides an optimistic view of the future and an effective adjustment mechanism that enable individuals to overcome current difficulties. Snyder (2002) suggested that hope should include goal-oriented energy and positive persistent intent to reach a goal, using an active cognitive process. According to Farran et al (1995):

‘Hope constitutes an essential experience of the human condition. It functions as a way of feeling, a way of thinking, a way of behaving, and a way of relating to oneself and one's world. Hope has the ability to be fluid in its expectations, and in the event that desired object or outcome does not occur, hope can still be present.’

Farran et al, 1995:6

Hope can make a difference to patients' experiences with chronic diseases and in the way they live their lives (Davison and Simpson, 2006; Ottaviani et al, 2014). Hope has a beneficial effect on individuals' health because it enables people to cope with conflicts, achieve healthy objectives, maintain QoL, and promote health (Sahaf et al, 2017; Bravin et al, 2019). Rahimipour et al (2015) conducted a clinical trial on the effect of hope therapy on anxiety, depression and stress among 50 patients undergoing HD. They found a significant reduction in mean scores of anxiety, depression and stress in the hope therapy group before and after the intervention, and that changes in mean scores of depression, anxiety and stress were lower in the hope therapy group compared with the placebo group. In another study, conducted with a random sample of 65 renal patients in Turkey, the findings indicated that lower levels of hope contributed to more depression and non-functional coping strategies among 50 patients with ESRD compared with the healthy control group (Yucens et al, 2019).

The meaning of hope and QoL of patients experiencing ESRD is shaped through cultural, social and family relationships (Melo et al, 2016; Al-Ghabeesh et al, 2018). The literature suggests that positive social support from families and friends increases the satisfaction of patients on dialysis with the care they receive and their QoL related to health in general (Silva et al, 2016). Cultural factors and beliefs were found to affect the patient's decision-making concerning treatment (Muscat et al, 2018).

Quality of life may be defined as:

‘The welfare of a patient on the basis of aspects of functional status (including physical, mental, and social factors) and a relative balance of expectations and experiences in the face of changing health.’

Abdel-Kader et al, 2009

Quality of life can be viewed as a person's feelings regarding their living status with reference to their personal objectives and expectations, according to their own cultural and value systems (Zhou et al, 2017). Compared with most chronic illnesses, ESRD is a debilitating, progressive and restricting disease that is likely to have a major impact on patients' health and, in particular, QoL and general wellbeing (Santos et al, 2017; Al Awwa and Jallad, 2018).

The increase in the number of patients receiving HD treatment and the increase in the prevalence of ESRD among the Jordanian population suggests that it is a growing problem that requires investigation into the role of hope in improving QoL so that health and social services could be tailored according to the health needs of the HD population. Despite the growing interest in examining all factors that may influence the QoL of patients with ESRD, studies emerging from the Arab world and, in particular, from Jordan, are extremely limited. The role of perceived hope in HD patients has not been fully investigated in Jordan. Therefore, this study aimed to examine levels of hope and examine hope association with QoL among people receiving HD treatment in Jordan.

Material and methods

Design, sample and settings

This was a cross-sectional exploratory study. All people receiving dialysis centre-based HD treatment across Jordan were considered eligible to participate. In 2016, there were 5352 patients receiving HD treatment; 5130 were Jordanians and 222 were non-Jordanians (Al-Qaisi and Assad, 2016:34). A convenience sampling strategy was used to recruit potential participants if they were:

  • In receipt of HD for more than 3 months
  • Aged ≥18 years
  • Able to read and communicate in Arabic
  • Willing to give informed consent.
  • The sample size was calculated using G*Power to produce meaningful outcomes (Faul et al, 2007). Using a small effect size of 0.20, alpha set at 0.05, and a power of 0.80, the desired sample size was calculated as a minimum of 150 subjects. The attrition rate was compensated by recruiting 50 more participants. In total, 202 patients participated in this study. The study was conducted in different dialysis centres distributed across the four major cities in Jordan. The total number of patients in these cities is more than 4000, representing 78% of the total number of Jordanian patients with ESRD (Al-Qaisi and Assad, 2016).

    Data collection procedure and ethical considerations

    A covering letter with details about the study was given out to all potential participants. After obtaining written informed consent, self-reported questionnaires were distributed, together with a demographic datasheet. The study was conducted over 7 months from October 2018 to April 2019.

    All appropriate ethical approvals were obtained before data collection. Potential participants were given a detailed explanation about the study and all signed a written informed consent form prior to data collection. Data were collected while patients were receiving HD treatment so that if answering the questions caused any distress, or they felt unwell, a specialist nurse or physician would be available to assist them. A password-protected computer was used to store collected data and all participants were assigned a random identification number to ensure confidentiality. All participants were assured that participation was voluntary and that they could withdraw at any time without consequences. They were also reassured that there were no right and wrong answers. They were asked to complete the questionnaires at their own pace without any influence from others.

    Measures

    The socio-demographic data included information about age, sex, level of education, income, employment status, marital status and previous medical history. Arabic versions of valid and reliable scales to measure hope and QoL were used.

    Hope

    The Arabic version of the Herth Hope Index (HHI) was used (Herth 1990). The HHI is a self-reporting scale comprising 12 items scored using a 4-point Likert-type scale (1=strongly disagree to 4=strongly agree). It was designed to be used in the clinical setting with acutely, chronically and terminally ill adults. Scores can range from 12 to 48, with higher scores indicating higher levels of hope (Herth, 1992). Herth (1992) reported internal consistency of 0.89 to 0.97 and a test–retest reliability coefficient of 0.91 for a variety of adult patient populations. The HHI has been translated into 33 languages (Herth, verbal communication). The Cronbach's alpha coefficient of the HHI in the study was .84.

    Quality of life

    The Arabic version of the World Health Organization (WHO) Quality of Life Questionnaire (WHOQOL-BREF) was used (WHO, 1996). It consists of 26 items rated on a 5-point Likert-type scale. Four domains calculated for these items included physical health, psychological health, social relationships and environment (WHOQOL Group, 1998). The score of each domain is calculated by adding up the domain-related items and then scores for each domain are calculated on a scale ranging from 0 to 100, in which high scores indicate a better QoL (WHO, 1996). The questionnaire demonstrated good internal consistency (Cronbach's alpha ranged between 0.66 for domain 3 (social relationships domain) and 0.84 for domain 1 (physical domain) and good discriminant validity (WHOQOL Group, 1998). The Arabic version of the WHOQOL-BREF has been used previously with many Arabic-speaking populations and demonstrated good internal consistency, reliability, and validity (Al Sayah et al, 2013). In the present study, Cronbach's alphas were 0.89, 0.84, 0.79, and 0.84 for the physical, psychological, social relationships, and environmental domains of QoL, respectively.

    Data analysis

    The data was analysed using SPSS version 24 with a significance level of 0.05. Descriptive statistics were used to describe the demographics and the clinical characteristics of the sample as appropriate to the level of measurement (mean ± standard deviation for continuous variables and number and percentage (n, %) for other categorical variables). Subjects who had completed data on the main study variables (Hope and QoL) were included in the analysis (202 out of 225) and, thus, there were some missing data on demographic variables as described in the related table presented in the results section.

    The levels of hope and QoL were described as mean and standard deviations. Respondents were categorised into two groups based on the level of hope, using the mean of the respondents' scores. To examine the associations between hope and QoL, the QoL scores were compared between subjects with low hope scores (below the mean) and subjects with high hope scores (above the mean) using independent sample t-tests.

    Results

    Socio-demographic characteristics

    As shown in Table 1, the subject's mean age was 47.89 (±15.22). About two-thirds were males (62.9%) and married (67.3%). Almost two-thirds of them were not employed (67.3%) or had comorbid conditions other than ESRD (68.3%). Hypertension was the most common comorbid condition (50%).


    Characteristic Mean ±SD or n(%)
    Age (years) 47.89±15.22
    Sex (male) 127 (62.9)
    Marital status
    Single 57 (28.2)
    Married 136 (67.3)
    Widowed or divorced 9 (4.5)
    Employment*
    Employed (full or part-time) 61 (30.2)
    Not employed 136 (67.3)
    Health insurance*
    No health insurance 23 (11.4)
    Public health insurance 69 (34.15)
    Military health insurance 99 (49)
    University health insurance 2 (1)
    History of chronic illness other than ESRD 140 (69.3)
    Number of chronic illnesses other than ESRD 1.8±1.39
    History of hypertension 101 (50)
    History of diabetes 60 (29.7)

    ESRD=end-stage renal disease; SD=standard deviation

    * Totals do not equal 202 because of missing data

    Levels of hope and QoL

    The respondents had relatively moderate levels of hope (Table 2). The overall hope scores on the HHI ranged from 15 to 42, with an overall mean score of 32.31 (±4.1). Concerning QoL, the sample had higher than the cut-off mean score of 50 for the psychological and social relationships domains (54.49±17.97 and 54.44±22.5, respectively), but not for the physical (48.32±21.14) and the environment (49.42±17.59) domains.


    Measure Possible range Actual range Mean ±SD
    Hope (Herth Hope Index) total scores 12–48 15–42 32.31±4.1
    QOL domains (WHOQOL-BREF)
    Physical health 0–100 0–94 48.32±21.14
    Psychological 0–100 13–100 54.49±17.97
    Social relationships 0–100 0–100 54.44±22.5
    Environment 0–100 6–88 49.42±17.59

    SD=Standard deviation; WHOQOL-BREF=World Health Organization Quality of Life tool, brief version

    Associations between hope and QoL

    As shown in Table 3, respondents with low hope scores had significantly lower (poorer) scores on all domains of QoL compared with those with high hope scores (41.3 vs. 55.5; 50.9 vs. 58.1; 47.1 vs. 62; and 43.1 vs. 56 for the physical, psychological, social relationships, and environment domains, respectively, all P values were <0.01).


    Low hope scorers High hope scorers t-test P-value
    QOL (WHOQOL-BREF)
    Physical domain 41.36±19.53 55.56±20.39 -5.053 <0.001
    Psychological domain 50.99±16.26 58.13±18.99 -2.873 <0.005
    Social relationships domain 47.18±21.4 62±21.19 -4.942 <0.001
    Environment domain 43.1±16.16 56±16.65 -5.584 <0.001

    WHOQOL BREF=World Health Organization Quality of Life tool, brief version

    * Low hope scorers group is the group who scored below the mean score on hope; high hope scorers group is the group who scored above the mean score on hope

    Discussion

    Given the rising prevalence of ESRD in Jordanians, it was imperative to study the factors related to this patient population's QoL. To the authors' knowledge, this study is the first in Jordan that explored the levels of hope among individuals with ESRD receiving HD and aimed to assess the associations between hope and QoL. The sample was drawn from a patient population that represents 78% of the total number of Jordanian patients with ESRD (Al-Qaisi and Assad, 2016). It was evident from the results that participants in this study had moderately elevated levels of hope and QoL. High levels of hope among individuals protect them against depression and anxiety. They develop more realistic goals and have reduced feelings of hopelessness, which can negatively affect their confidence. Consequently, they become more resistant to the effects of negative events (Rahimipour et al, 2015). In contrast, Yucens et al (2019) and Orlandi et al (2012) used the HHI in patients with chronic renal diseases and reported a low level of hope scores among their participants. These variations in the findings are interesting and worth further examination to find out the reasons behind them. However, one of the reasons for these variations between the authors' study and that of Orlandi et al (2012) might be because the patients in the present study had an average age of 47 years, compared with an age range of 67 to 73 years in Orlandi et al's (2012) study. The fact that participants with low hope levels achieved lower scores on the social relationship domain of QoL seems to be related to the debilitating nature of the disease that potentially disrupts the physical, psychological, and social wellness of this patient population. This was similar to what was reported in the study by Daąbrowska-Bender et al (2018), where individuals undergoing HD for ESRD experienced various physiological and psychological limitations that negatively influenced their overall wellbeing. Moreover, the authors' finding indicates that the negative impact of the disease manifested in the high percentage of unemployment (67%) among this sample population. This was similar to what has been reported in another study representing other populations with ESRD receiving HD (Hallab and Wish, 2018).

    Findings supported an association between hope and QoL. It was shown that increased levels of hope were associated with an improved perceived QoL. Similar results were reported in the literature where higher levels of hope led to improved coping among individuals with ESRD and treated with HD (Taheri-Kharameh, 2016). Rahimipour et al (2015) reported that achieving higher levels of hope following hope therapy predicted reduced psychological distress represented in depression, anxiety and stress among individuals with ESRD treated with HD. Therefore, the results of the present study seem to support the notion that hope might help in reducing psychological distress, which may improve QoL among this patient population (Yucens et al, 2019). It is noteworthy that, among individuals with other chronic diseases, using hope intervention therapies as a learned coping strategy proved successful in reducing psychological distress. Examples were among individuals with multiple sclerosis (Khodabakhshi-Koolaee et al, 2017), diabetes mellitus (Ghazavi et al, 2018), and cancer (Tamadon and Askari, 2015). Therefore, using hope therapy seems a useful intervention for individuals with ESRD treated with HD to positively influence their coping with their condition. Research aiming to positively influence coping among individuals with ESRD receiving HD in Jordan should focus more on adopting hope as an intervention to improve patients' overall health outcomes and, in particular, their QoL.

    Implications for practice

    Nurses play a vital role in the care of patients receiving HD treatment. The study's findings imply that patients' QoL could be improved in those who have a high level of hope. Hence, frequent assessment of hope among those patients might be beneficial in terms of interventions that could be implemented in the dialysis units. Nurses should incorporate the assessment of hope as part of their formal routine care for patients on HD. To do so, nurses can ask questions, including open-ended questions about patients' level of hope, source of hope, factors that may influence their hope level, and how hope can affect their lives and their health outcomes. Nurses also have the responsibility to encourage, promote and instil hope among their patients. Thus nurses can play an important role in fostering hope among their patients. Jahromi et al (2016) suggested that providing education for HD patients, and finding a suitable method of following up those patients, may improve the level of hope among them. Health professionals, including nurses, are advised to reassure individuals about their condition and treatment and emphasise the positive side of their condition as a method of improving hope. However, false assurance needs to be avoided as it may have a negative impact on the patients (Scanlon, 1989). Some of the activities that might be used to promote hope in terminally ill patients according to Scanlon (1989) include frequent hope and psychological assessment, providing emotional support, setting healthcare-related goals and priorities, and teaching and creating an environment that maximises self-worth and human potentials. Lastly, nurses can improve the level of hope in HD patients by establishing supportive relationships with them, reassessing perceived challenges or conditions causing stress and seeing these as opportunities for improvements. They could also help by supporting patients to focus on their current life and not to worry about the future, as well as help with establishing appropriate expectations and achievable goals, and discussions about spiritual practices and activities.

    Limitations

    This study was limited by the cross-sectional design used and the convenient sampling strategy. More research using various research methodologies (eg randomised controlled trials or experimental studies) to examine hope and its association with QoL is needed. However, the study was conducted and recruited participants from different dialysis centres across Jordan and this may increase the strength of its findings.

    Conclusion

    The study shows that people receiving HD treatment in Jordan had moderate levels of hope. The study also sheds light on the importance of the concept of hope in its potential relationship with the QoL of this population. The results showed that QoL could be improved by improving the level of hope. Thus, nurses need to regularly assess hope in this population and intervene accordingly. Future studies on these relationships especially interventional studies are warranted.

    KEY POINTS

  • This study examined levels of hope and quality of life (QoL) in people receiving haemodialysis treatment
  • Haemodialysis treatment negatively impacts patients' QoL and, in particular, their physical domain
  • Those with higher levels of hope reported better QoL
  • Nurses should assess hope, provide emotional support, and set healthcare-related goals and priorities to maximise self-worth and human potential among this patient group
  • Nurses should establish supportive relationships with patients, reassess perceived challenges causing stress and consider these as opportunities for improvement
  • CPD reflective questions

  • Haemodialysis treatment has been shown to affect patients' quality of life. Think about other areas of a person's life that might be affected by receiving haemodialysis
  • Reflect on the type of care delivered in your practice and whether this type of care addresses hope in the planned care of patients
  • Think about how you could include/develop interventions to promote hope that could be implemented in your area of practice that could improve your patients' health outcomes and, in particular, their quality of life